TotalMarketCap

Natures Sunshine Products

NATRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$176.580 M

$10.19 -20.64%

Close of 6 Nov 2026

As of 6 Nov 2026, Natures Sunshine Products (NATR) has a market capitalization of $176.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$480.1M

#1913 by revenue

Earnings

$19.5M

#1867 by earnings

Shares outstanding

17,328,776

Latest filing cover page

P/E ratio

9.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #252Keros TherapeuticsKROS$187.6M
  2. #253Entrada TherapeuticsTRDA$176.8M
  3. #254Natures Sunshine ProductsNATR$176.6M
  4. #255Upstream BioUPB$175.8M
  5. #256BridgeBio Oncology TherapeuticsBBOT$175.2M

What if Natures Sunshine Products were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,629,479

Per share 159,910× higher

Bitcoin $1.53T

$88,168.26

Per share 8,652× higher

Apple $5.02T

$289,448.18

Per share 28,405× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Natures Sunshine Products are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.